GUARDANT HEALTH, INC. Revenue
GUARDANT HEALTH, INC. (GH) reported Revenue of $334.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2026-07-30
- GUARDANT HEALTH, INC. revenues for the quarter ending 2026-06-30 was $334.98M, a 44.33% increase year-over-year.
- GUARDANT HEALTH, INC. revenues for the quarter ending 2026-03-31 was $301.67M, a 48.26% increase year-over-year.
- GUARDANT HEALTH, INC. revenues for the quarter ending 2025-12-31 was $281.27M, a 39.37% increase year-over-year.
- GUARDANT HEALTH, INC. revenues for the quarter ending 2025-09-30 was $265.20M, a 38.50% increase year-over-year.
- GUARDANT HEALTH, INC. revenues for fiscal 2025 was $982.02M, a 32.88% increase from fiscal 2024.
- GUARDANT HEALTH, INC. revenues for fiscal 2024 was $739.02M, a 31.04% increase from fiscal 2023.
- GUARDANT HEALTH, INC. revenues for fiscal 2023 was $563.95M, a 25.45% increase from fiscal 2022.
- GUARDANT HEALTH, INC. revenues for fiscal 2022 was $449.54M, a 20.31% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $334.98M 10-Q · filed 2026-07-30 | $636.64M 10-Q · filed 2026-07-30 | $917.91M derived: sum of 3 quarters · filed 2026-07-30 | $1.18B derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $301.67M 10-Q · filed 2026-05-07 | $582.93M derived: sum of 2 quarters · filed 2026-05-07 | $848.13M derived: sum of 3 quarters · filed 2026-05-07 | $1.08B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $281.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $546.46M derived: sum of 2 quarters · filed 2026-02-19 | $778.55M derived: sum of 3 quarters · filed 2026-07-30 | $982.02M 10-K · filed 2026-02-19 |
| 2025-09-30 | $265.20M 10-Q · filed 2025-10-29 | $497.28M derived: sum of 2 quarters · filed 2026-07-30 | $700.75M 10-Q · filed 2025-10-29 | $902.57M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $232.09M 10-Q · filed 2026-07-30 | $435.56M 10-Q · filed 2026-07-30 | $637.37M derived: sum of 3 quarters · filed 2026-07-30 | $828.85M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $203.47M 10-Q · filed 2026-05-07 | $405.29M derived: sum of 2 quarters · filed 2026-05-07 | $596.76M derived: sum of 3 quarters · filed 2026-05-07 | $774.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $201.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $393.29M derived: sum of 2 quarters · filed 2026-02-19 | $570.52M derived: sum of 3 quarters · filed 2026-02-19 | $739.02M 10-K · filed 2026-02-19 |
| 2024-09-30 | $191.48M 10-Q · filed 2025-10-29 | $368.71M derived: sum of 2 quarters · filed 2025-10-29 | $537.20M 10-Q · filed 2025-10-29 | $692.26M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $177.24M 10-Q · filed 2025-07-30 | $345.73M 10-Q · filed 2025-07-30 | $500.78M derived: sum of 3 quarters · filed 2026-02-19 | $643.81M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $168.49M 10-Q · filed 2025-04-30 | $323.55M derived: sum of 2 quarters · filed 2026-02-19 | $466.57M derived: sum of 3 quarters · filed 2026-02-19 | $603.73M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $155.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $298.08M derived: sum of 2 quarters · filed 2026-02-19 | $435.23M derived: sum of 3 quarters · filed 2026-02-19 | $563.95M 10-K · filed 2026-02-19 |
| 2023-09-30 | $143.03M 10-Q · filed 2024-11-06 | $280.18M derived: sum of 2 quarters · filed 2024-11-06 | $408.89M 10-Q · filed 2024-11-06 | $535.78M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $137.15M 10-Q · filed 2024-08-07 | $265.86M 10-Q · filed 2024-08-07 | $392.75M derived: sum of 3 quarters · filed 2025-02-20 | $510.16M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $128.71M 10-Q · filed 2024-05-09 | $255.60M derived: sum of 2 quarters · filed 2025-02-20 | $373.01M derived: sum of 3 quarters · filed 2025-02-20 | $482.15M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $126.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $244.29M derived: sum of 2 quarters · filed 2025-02-20 | $353.44M derived: sum of 3 quarters · filed 2025-02-20 | $449.54M 10-K · filed 2025-02-20 |
| 2022-09-30 | $117.40M 10-Q · filed 2023-11-06 | $226.55M derived: sum of 2 quarters · filed 2023-11-06 | $322.65M 10-Q · filed 2023-11-06 | $430.75M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $109.14M 10-Q · filed 2023-08-03 | $205.24M 10-Q · filed 2023-08-03 | $313.35M derived: sum of 3 quarters · filed 2024-02-22 | $408.13M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $96.10M 10-Q · filed 2023-05-09 | $204.21M derived: sum of 2 quarters · filed 2024-02-22 | $298.99M derived: sum of 3 quarters · filed 2024-02-22 | $391.09M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $108.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $202.89M derived: sum of 2 quarters · filed 2024-02-22 | $294.99M derived: sum of 3 quarters · filed 2024-02-22 | $373.65M 10-K · filed 2024-02-22 |
| 2021-09-30 | $94.78M 10-Q · filed 2022-11-03 | $186.88M derived: sum of 2 quarters · filed 2022-11-03 | $265.55M 10-Q · filed 2022-11-03 | $343.86M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $92.10M 10-Q · filed 2022-08-04 | $170.77M 10-Q · filed 2022-08-04 | $249.08M derived: sum of 3 quarters · filed 2023-02-23 | $323.65M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $78.67M 10-Q · filed 2022-05-05 | $156.98M derived: sum of 2 quarters · filed 2023-02-23 | $231.55M derived: sum of 3 quarters · filed 2023-02-23 | $297.88M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $78.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $152.88M derived: sum of 2 quarters · filed 2023-02-23 | $219.22M derived: sum of 3 quarters · filed 2023-02-23 | $286.73M 10-K · filed 2023-02-23 |
| 2020-09-30 | $74.57M 10-Q · filed 2021-11-04 | $140.90M derived: sum of 2 quarters · filed 2021-11-04 | $208.41M 10-Q · filed 2021-11-04 | $271.31M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $66.33M 10-Q · filed 2021-08-05 | $133.84M 10-Q · filed 2021-08-05 | $196.74M derived: sum of 3 quarters · filed 2022-02-24 | $257.59M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $67.51M 10-Q · filed 2021-05-06 | $130.41M derived: sum of 2 quarters · filed 2022-02-24 | $191.25M derived: sum of 3 quarters · filed 2022-02-24 | $245.23M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $62.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $123.75M derived: sum of 2 quarters · filed 2022-02-24 | $177.72M derived: sum of 3 quarters · filed 2022-02-24 | $214.38M 10-K · filed 2022-02-24 |
| 2019-09-30 | $60.85M 10-Q · filed 2020-11-05 | $114.82M derived: sum of 2 quarters · filed 2020-11-05 | $151.48M 10-Q · filed 2020-11-05 | $184.35M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $53.98M 10-Q · filed 2020-08-06 | $90.63M 10-Q · filed 2020-08-06 | $123.50M derived: sum of 3 quarters · filed 2021-02-25 | $145.19M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $36.66M 10-Q · filed 2020-05-07 | $69.53M derived: sum of 2 quarters · filed 2021-02-25 | $91.22M derived: sum of 3 quarters · filed 2021-02-25 | $110.60M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $32.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $54.56M derived: sum of 2 quarters · filed 2021-02-25 | $73.95M derived: sum of 3 quarters · filed 2021-02-25 | $90.64M 10-K · filed 2021-02-25 |
| 2018-09-30 | $21.69M 10-Q · filed 2019-11-07 | $41.07M derived: sum of 2 quarters · filed 2019-11-07 | $57.77M 10-Q · filed 2019-11-07 | $77.77M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $19.38M 10-Q · filed 2019-08-07 | $36.07M 10-Q · filed 2019-08-07 | $56.08M derived: sum of 3 quarters · filed 2020-03-02 | $67.21M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $16.69M 10-Q · filed 2019-05-10 | $36.69M derived: sum of 2 quarters · filed 2020-03-02 | $47.83M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $31.13M derived: sum of 2 quarters · filed 2020-03-02 | $49.84M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $11.13M 10-Q · filed 2018-11-19 | $29.84M 10-Q · filed 2018-11-19 | ||
| 2016-12-31 | $25.25M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |